XLV240726C160000
- 0.00
- 0.000.00%
The Health Care Select Sector SPDR® Fund Newsroom
JPMorgan Chase Adjusts Price Target on UnitedHealth to $652 From $559
A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $200 to $214
Morgan Stanley Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $655
Morgan Stanley Adjusts AbbVie Price Target to $211 From $196
AbbVie Analyst Ratings
Buy Rating Affirmed for AbbVie Amidst Strong Financials and Strategic Management
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
Evercore Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $605
Thermo Fisher Price Target Raised to $658.00/Share From $648.00 by TD Cowen
Piper Sandler Adjusts Price Target on AbbVie to $196 From $190
Redburn Atlantic Adjusts Price Target on Danaher to $280 From $260
Raymond James Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $660
Navigating 5 Analyst Ratings For Thermo Fisher Scientific
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $600 to $664
Argus Research Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $300
Cantor Fitzgerald Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $885
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $655 From $650, Maintains Buy Rating
Thermo Fisher Price Target Raised to $632.00/Share From $620.00 by Baird
Thermo Fisher Scientific Analyst Ratings
Eli Lilly and Co Analyst Ratings